103 related articles for article (PubMed ID: 11056085)
1. Nitric oxide and viral cardiomyopathy.
Finkel MS
Circulation; 2000 Oct; 102(18):2162-4. PubMed ID: 11056085
[No Abstract] [Full Text] [Related]
2. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B
Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
[TBL] [Abstract][Full Text] [Related]
6. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
[TBL] [Abstract][Full Text] [Related]
7. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
Badorff C; Knowlton KU
Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
[TBL] [Abstract][Full Text] [Related]
8. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis.
Colston JT; Chandrasekar B; Freeman GL
Cardiovasc Res; 1998 Apr; 38(1):158-68. PubMed ID: 9683918
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide inhibits viral replication in murine myocarditis.
Lowenstein CJ; Hill SL; Lafond-Walker A; Wu J; Allen G; Landavere M; Rose NR; Herskowitz A
J Clin Invest; 1996 Apr; 97(8):1837-43. PubMed ID: 8621766
[TBL] [Abstract][Full Text] [Related]
11. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis.
Zaragoza C; Ocampo C; Saura M; Leppo M; Wei XQ; Quick R; Moncada S; Liew FY; Lowenstein CJ
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2469-74. PubMed ID: 9482909
[TBL] [Abstract][Full Text] [Related]
12. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
13. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide.
Matsumori A
Jpn Circ J; 1997 Apr; 61(4):275-91. PubMed ID: 9152779
[TBL] [Abstract][Full Text] [Related]
14. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.
Lim BK; Yun SH; Ju ES; Kim BK; Lee YJ; Yoo DK; Kim YC; Jeon ES
Virus Res; 2015 Mar; 199():1-8. PubMed ID: 25485472
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
Lee GH; Badorff C; Knowlton KU
Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
[TBL] [Abstract][Full Text] [Related]
16. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.
Szalay G; Sauter M; Hald J; Weinzierl A; Kandolf R; Klingel K
Am J Pathol; 2006 Dec; 169(6):2085-93. PubMed ID: 17148671
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
Jarasch N; Martin U; Kamphausen E; Zell R; Wutzler P; Henke A
Viral Immunol; 2005; 18(2):355-64. PubMed ID: 16035947
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli.
Zamora R; Vodovotz Y; Alarcon L; Betten B; Loughran PA; Aulak KS; Stuehr DJ; Gibson KF; Billiar TR
Arch Biochem Biophys; 2001 Jun; 390(2):287-94. PubMed ID: 11396931
[TBL] [Abstract][Full Text] [Related]
19. Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy.
Afzal MZ; Reiter M; Gastonguay C; McGivern JV; Guan X; Ge ZD; Mack DL; Childers MK; Ebert AD; Strande JL
J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):549-562. PubMed ID: 26940570
[TBL] [Abstract][Full Text] [Related]
20. Role of inducible nitric-oxide synthase in regulation of whole-cell current in lung epithelial cells.
Kamosinska B; Radomski A; Man SF; Radomski MW; Duszyk M
J Pharmacol Exp Ther; 2000 Nov; 295(2):500-5. PubMed ID: 11046081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
